Clinical Trial Update: Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for radiation with cisplatin or panitumumab in locally advanced head and neck cancer; results completed with posted results in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Panitumumab (panitumumab)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Head and Neck Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-06-20